Provider: Pechala's Reports
Signal Genetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Signal Genetics announces pricing of initial public offering of common stock
Signal Genetics:Prices initial public offering of 850,000 shares of its common stock offered at a price to public of $10.00 per share.Gross proceeds to Signal Genetics from initial public offering are expected to be $8,500,000, before underwriting discounts and commissions and other offering expenses.Grants representative of underwriters a 45-day option to purchase up to 127,500 additional shares of common stock to cover over-allotments, if any.Expects shares to begin trading on The NASDAQ Capital Market under the symbol SGNL on June 18.Offering is expected to close on June 23.Aegis Capital Corp. is acting as sole book-running manager for offering.
Latest Developments for Signal Genetics Inc
Latest Key Developments in Healthcare
- S H L Telemedicine Ltd says Elon Shalev elected Chairman
- Singapore Medical Group Ltd enters into non-binding memorandum of understanding with Leaders Cosmetics Division of Sansung Life & Science Co., Ltd
- Egyptian Stock Exchange approves Cairo Medical Center SAE de-listing request
- Retroscreen Virology Group Plc gives FY 2014 revenue outlook
- Share this
- Digg this